Wednesday, December 06, 2023 11:27:44 PM
flipper44,
I don’t see a mea culpa. I see what the company has done with regard to strategic use of safe harbor statements and I have said this off and on for years. When I say the company used longs it’s because they needed long support any way they could get it and they have said they appreciate that support but they most certainly have taken advantage of that relationship with the understanding that they expected those who stuck it out with them would be the ones eventually rewarded. They also understand why there are longs that trade in and out or have traded in and out with some of their shares. Opportunity cost and time is not on every investor’s side. Pretty obvious that thermo has been truthful about this and I shared that I bought extra shares that I later sold back only to build my position up well beyond that point afterwards consistent with my long term goal to accumulate when the market makers and traders work the cycles. I have shared the baseline uptrend from the double bottom in March/April 2020 that all longs could have been using to continue building share count over time if they so chose. Even though I have been off with time line expectations, as most of us hoped for artisan method approval to come sooner, I have always stated I am in to the end. I can point back to earlier posts if anyone would chose to disagree with this.
You wrestled with the need for Edens manufacturing that they did not have vs artisan being able to supply demand and pointed out the potential of side by side BLA preparedness in the last 24 hours. Obviously something else seemed to be required of them than artisan method based on all the delays to submission.
How long have I been focused on manufacturing? The constraints on availability caused by product release restrictions, mentioned specifically by NWBO, were supposed to be able to be overcome on paper with artisan methods but somehow the company couldn’t seem to get an earlier BLA done with that method even after the MIA certification which was likely based on it. NWBO has been buying time in my opinion and investors were just supposed to continue trusting and supporting them in that effort because they could not spell it out without getting hammered by short sellers and longs willing to exit then repurchase later which would have meant even more dilution than has taken place by having everyone expecting everything at any time. The bears have consistently tried to separate loyal longs from management by painting management as adversarial self interested parties. I don’t believe that for one minute but neither will they spell everything out for investors because of how that would be used against them. Hence, the use of safe harbor and longs needing to understand and learn how to deal with it over all these years. We have all been willing participants at this table with the hope and expectation that the basis for our investment is sound and leads to the better day for patients and well deserved reward for those who ground it out with NWBO to the finish. Best wishes.
I don’t see a mea culpa. I see what the company has done with regard to strategic use of safe harbor statements and I have said this off and on for years. When I say the company used longs it’s because they needed long support any way they could get it and they have said they appreciate that support but they most certainly have taken advantage of that relationship with the understanding that they expected those who stuck it out with them would be the ones eventually rewarded. They also understand why there are longs that trade in and out or have traded in and out with some of their shares. Opportunity cost and time is not on every investor’s side. Pretty obvious that thermo has been truthful about this and I shared that I bought extra shares that I later sold back only to build my position up well beyond that point afterwards consistent with my long term goal to accumulate when the market makers and traders work the cycles. I have shared the baseline uptrend from the double bottom in March/April 2020 that all longs could have been using to continue building share count over time if they so chose. Even though I have been off with time line expectations, as most of us hoped for artisan method approval to come sooner, I have always stated I am in to the end. I can point back to earlier posts if anyone would chose to disagree with this.
You wrestled with the need for Edens manufacturing that they did not have vs artisan being able to supply demand and pointed out the potential of side by side BLA preparedness in the last 24 hours. Obviously something else seemed to be required of them than artisan method based on all the delays to submission.
How long have I been focused on manufacturing? The constraints on availability caused by product release restrictions, mentioned specifically by NWBO, were supposed to be able to be overcome on paper with artisan methods but somehow the company couldn’t seem to get an earlier BLA done with that method even after the MIA certification which was likely based on it. NWBO has been buying time in my opinion and investors were just supposed to continue trusting and supporting them in that effort because they could not spell it out without getting hammered by short sellers and longs willing to exit then repurchase later which would have meant even more dilution than has taken place by having everyone expecting everything at any time. The bears have consistently tried to separate loyal longs from management by painting management as adversarial self interested parties. I don’t believe that for one minute but neither will they spell everything out for investors because of how that would be used against them. Hence, the use of safe harbor and longs needing to understand and learn how to deal with it over all these years. We have all been willing participants at this table with the hope and expectation that the basis for our investment is sound and leads to the better day for patients and well deserved reward for those who ground it out with NWBO to the finish. Best wishes.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
